vimarsana.com

உதவியாளர் ஆராய்ச்சி விஞ்ஞானி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study reveals contributing factor to inconsistent results in clinical trials for COVID-19 drugs

Study reveals contributing factor to inconsistent results in clinical trials for COVID-19 drugs Jul 8 2021 A new study suggests that significant variation in the amount of virus from person to person may be a contributing factor to inconsistent findings reported in clinical trials for antiviral COVID-19 drugs. The study is led by Keisuke Ejima, an assistant research scientist at the Indiana University School of Public Health-Bloomington. A new study suggests that significant variation in the amount of virus from person to person may be a contributing factor to inconsistent findings reported in clinical trials for antiviral COVID-19 drugs. Photo courtesy of Getty Images

New genetic editing tools could stop the spread of mosquito diseases

New genetic editing tools could stop the spread of mosquito diseases Since the onset of the CRISPR genetic editing revolution, scientists have been working to leverage the technology in the development of gene drives that target pathogen-spreading mosquitoes such as Anopheles and Much less genetic engineering has been devoted to Culex genus mosquitoes, which spread devastating afflictions stemming from West Nile virus-;the leading cause of mosquito-borne disease in the continental United States-;as well as other viruses such as the Japanese encephalitis virus (JEV) and the pathogen causing avian malaria, a threat to Hawaiian birds. University of California San Diego scientists have now developed several genetic editing tools that help pave the way to an eventual gene drive designed to stop

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.